Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-14
2007-08-14
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S117000
Reexamination Certificate
active
10769536
ABSTRACT:
Composition and methods of treating pain and reducing, reversing, or preventing tolerance to opiate analgesics are disclosed. The composition and method utilize an opiate analgesic and a calcium calmodulin kinase (CaMKII) inhibitor as active agents to treat pain in mammals, including humans.
REFERENCES:
patent: 5321012 (1994-06-01), Mayer et al.
patent: 5502058 (1996-03-01), Mayer et al.
patent: 5523323 (1996-06-01), Maccecchini
patent: 5866154 (1999-02-01), Bahal et al.
patent: 6043224 (2000-03-01), Lee et al.
patent: 6432652 (2002-08-01), Evans et al.
patent: 6518245 (2003-02-01), Anderson et al.
patent: 6869440 (2005-03-01), Dobak, III
patent: 0 608 893 (1994-08-01), None
patent: 0 911 039 (1999-04-01), None
FDA Approves Two Drugs to Treat Opiate Dependence, Forbes, Oct. 8, 2002, p. 1, http://www.webprowire.com/summaries/266443.html, printed Mar. 21, 2005.
Vicodin Addiction, 2004, p. 1, http://www.vicodin-addiction.org/, printed Mar. 29, 2006.
Fan G-H et al.: “Inhibition of Calcium/Calmodulin-Dependent Protein Kinase II in Rat Hippocampus Attenuates Morphine Tolerance and Dependence”, 1999, Molecular Pharmacology, vol. 56. pp. 39-45.
Gonzalez G. et al.: “Combating Opiate Dependence: A Comparison Among the Available Pharmacological Options”, 2004, Expert Opin. Pharmacother. vol. 5. pp. 713-725.
Wang et al. “Reversal of Morphine Antinociceptive Tolerance By Acute Spinal Inhibition of Ca/Calmodulin-Dependent Protein Kinase II”, (Mar. 2003), European Journal of Pharmacology, vol. 465. pp. 199-200.
A. Mestek et al.,The Journal of Neuroscience, 15(3):2396-2406 (1995).
T. Koch et al.,Journal of Neurochemistry, vol. 69, No. 4, 1767-1770 (1997).
L. Lou et al.,Molecular Pharmacology, 55:557-563 (1999).
Z. Wang et al.,Life Sciences, vol. 54, No. 20, pp. 339-350 (1994).
G-H. Fan et al.,Molecular Pharmacology, 56:39-45 (1999).
P. Nitescu et al.,Eur. J. Pain, 13, 3, 76-88 (1992).
Tan et al., “Trifluoperazine, an orally available clinically used drug, disrupts opioid antinoiceptive tolerance”, Neuroscience Letters 2005 1-4.
Khanna Hemant
Licata & Tyrrell P.C.
The Board of Trustees of the University of Illinois, a body corp
Tsang Cecilia J.
LandOfFree
Method and composition for potentiating an oplate analgesic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for potentiating an oplate analgesic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for potentiating an oplate analgesic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888358